Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Cancer. 2011 Jun 1;117(11):2371-8. doi: 10.1002/cncr.25778. Epub 2011 Jan 11.
The seventh edition of the American Joint Committee on Cancer (AJCC) TNM classification for gastric cancer was published in 2010 and included major revisions. The aim of the current study was to evaluate the validity of the seventh edition TNM classification for gastric cancer based on an Asian population.
A total of 2916 gastric cancer patients who underwent R0 surgical resection from 1989 through 2008 in a single institute were included, and were analyzed according to the seventh edition of the TNM classification for validation.
When adjusted using the seventh edition of the TNM classification, upstaging was observed in 771 patients (26.4%) and downstaging was observed in 178 patients (6.1%) compared with the sixth edition of the TNM classification. The relative risk (RR) of seventh edition pT classification was found to be increased with regular intensity compared with the sixth edition pT classification. The RR of seventh edition pN classification was found to be increased with irregular intensity compared with the sixth edition pN classification. In survival analysis, there were significant differences noted for each stage of disease, but only a marginal difference was demonstrated between stage IA and stage IB (P = .049). In the hybrid TNM classification, which combines the seventh edition pT classification and the sixth edition pN classification, both pT and pN classifications demonstrated a more ideal distribution of the RR, and 5-year survival rates also showed a significant difference for each stage (P <.01).
The seventh edition of the TNM classification was considered valid based on the results of the current study. However, the hybrid TNM classification, comprised of a combination of the seventh edition pT classification and sixth edition pN classification, should be considered for the next edition.
美国癌症联合委员会(AJCC)第七版胃癌 TNM 分期于 2010 年发布,其中包含了重大修订。本研究旨在基于亚洲人群评估第七版胃癌 TNM 分期的有效性。
共纳入了 1989 年至 2008 年在单家医院接受 R0 手术切除的 2916 例胃癌患者,根据第七版 TNM 分期进行验证分析。
与第六版 TNM 分期相比,第七版分期中,771 例(26.4%)患者分期升高,178 例(6.1%)患者分期降低。与第六版 pT 分期相比,第七版 pT 分期的相对风险(RR)随着强度的增加而增加。与第六版 pN 分期相比,第七版 pN 分期的 RR 随着强度的增加而增加。生存分析显示,各期疾病之间存在显著差异,但 IA 期和 IB 期之间差异仅为边缘性(P =.049)。在混合 TNM 分期中,结合了第七版 pT 分期和第六版 pN 分期,pT 和 pN 分期的 RR 分布更加理想,各期 5 年生存率也存在显著差异(P <.01)。
根据本研究结果,第七版 TNM 分期被认为是有效的。然而,下一个版本应考虑使用第七版 pT 分期和第六版 pN 分期相结合的混合 TNM 分期。